ID

31686

Descripción

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC); ODM derived from: https://clinicaltrials.gov/show/NCT01326559 Collaborating Parties: The University of Hong Kong Sanofi Merck Sharp & Dohme Corp. Roche Pharma AG

Link

https://clinicaltrials.gov/show/NCT01326559

Palabras clave

  1. 16/9/18 16/9/18 -
  2. 21/9/18 21/9/18 -
Titular de derechos de autor

Hong Kong Nasopharyngeal Cancer Study Group Limited

Subido en

21 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Nasopharyngeal Carcinoma NCT01326559

Eligibility Nasopharyngeal Carcinoma NCT01326559

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous autologous stem cell transplantation within 6 months
Descripción

Transplantation of autologous hematopoietic stem cell

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1831743
previous allogeneic stem cell transplantation
Descripción

Allogeneic Stem Cell Transplantation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2242529
more than 1 previous radio immunotherapy regimen
Descripción

Radioimmunotherapy Previous Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085101
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C1265611
received radio immunotherapy within 3 months
Descripción

Radioimmunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085101
received any anti-cancer treatment within 4 weeks
Descripción

Cancer treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920425
received monoclonal antibodies, other than rituximab within 3 months
Descripción

Monoclonal Antibodies | Exception Rituximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003250
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0393022
patients previously treated with anti-cd20 monoclonal antibodies, other than rituximab
Descripción

Anti-CD20 Antibody | Exception Rituximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3891557
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0393022
life expectancy less than 6 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01326559

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Item Group
C0680251 (UMLS CUI)
Transplantation of autologous hematopoietic stem cell
Item
previous autologous stem cell transplantation within 6 months
boolean
C1831743 (UMLS CUI [1])
Allogeneic Stem Cell Transplantation
Item
previous allogeneic stem cell transplantation
boolean
C2242529 (UMLS CUI [1])
Radioimmunotherapy Previous Quantity
Item
more than 1 previous radio immunotherapy regimen
boolean
C0085101 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Radioimmunotherapy
Item
received radio immunotherapy within 3 months
boolean
C0085101 (UMLS CUI [1])
Cancer treatment
Item
received any anti-cancer treatment within 4 weeks
boolean
C0920425 (UMLS CUI [1])
Monoclonal Antibodies | Exception Rituximab
Item
received monoclonal antibodies, other than rituximab within 3 months
boolean
C0003250 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0393022 (UMLS CUI [2,2])
Anti-CD20 Antibody | Exception Rituximab
Item
patients previously treated with anti-cd20 monoclonal antibodies, other than rituximab
boolean
C3891557 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0393022 (UMLS CUI [2,2])
Life Expectancy
Item
life expectancy less than 6 months
boolean
C0023671 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial